Skip to main content
Article
Effects of antipsychotic medication on muscarinic M1 receptor mRNA expression in the rat brain
Faculty of Health and Behavioural Sciences - Papers (Archive)
  • Kelly A Newell, University of Wollongong
  • Xu-Feng Huang, University of Wollongong
  • Katerina Zavitsanou, University of Wollongong
  • Chao Deng, University of Wollongong
  • Mei Han, University of Wollongong
RIS ID
22343
Publication Date
1-1-2008
Publication Details

Han, M., Newell, K. A., Zavitsanou, K., Deng, C. & Huang, X. (2008). Effects of antipsychotic medication on muscarinic M1 receptor mRNA expression in the rat brain. Journal of Neuroscience Research, 86 (2), 457-464.

Abstract

Alterations in muscarinic M1 receptor protein and mRNA expression have been revealed in post-mortem brains of schizophrenia patients. Most patients had been treated with antipsychotics, so medication effects cannot be excluded as a possible explanation for these results. With in situ hybridization, this study investigated M1 receptor mRNA expression in rats treated with the typical antipsychotic haloperidol (0.3 mg/kg/day) and the atypical antipsychotics olanzapine (1.5 mg/kg/day) and aripiprazole (2.25 mg/kg/day) for 1 or 12 weeks. Compared with the control group, haloperidol significantly increased (13-21%, P < 0.05) M1 mRNA expression in the CA1, CA2, and CA3 regions of the hippocampus after both 1 and 12 weeks of treatment, and it also increased (17%, P < 0.01) M1 mRNA expression in the substantia nigra compacta after 1 week of treatment. Olanzapine significantly increased (14-22%, P < 0.05) M1 mRNA expression in the hippocampus (CA1, CA2, and CA3) and substantia nigra compacta after 12 weeks of treatment, but not after 1 week. Aripiprazole significantly increased (17%, P < 0.01) M1 mRNA expression in the hippocampus (CA1) after both 1 and 12 week treatments and increased (12%, P < 0.05) M1 mRNA expression in the nucleus accumbens after 1 week of treatment. Despite their different affinities for muscarinic M1 receptors, all three antipsychotic medications induced a similar trend of change in M1 mRNA expression in selected brain regions. These data suggest that the decreased M1 receptor protein and mRNA expression observed in schizophrenia patients is unlikely to be a consequence of drug treatments and implicates muscarinic M1 receptors in the pharmacotherapy of the disease. © 2007 Wiley-Liss, Inc.

Citation Information
Kelly A Newell, Xu-Feng Huang, Katerina Zavitsanou, Chao Deng, et al.. "Effects of antipsychotic medication on muscarinic M1 receptor mRNA expression in the rat brain" (2008) p. 457 - 464
Available at: http://works.bepress.com/xhuang/38/